Background
==========

The intestinal epithelial barrier (IEB) is the first boundary between the organism and the luminal environment. It plays a dual role by allowing the passage of nutrients and electrolytes but preventing the passage of pathogens. The maintenance of its homeostasis is of utmost importance for the survival of the organism. The IEB is formed by a monolayer of specialized intestinal epithelial cells (IEC) under constant renewal and maintained together *via*various cell-to-cell and cell-to-matrix interactions. The IEB is part of a complex network of specialized cell types constituting its microenvironment such as immune cells, subepithelial fibroblasts, endothelial cells or luminal bacteria. Emerging evidences suggest that under physiological conditions, the IEB\'s functions are actively regulated by its cellular microenvironment \[[@B1]-[@B3]\]. For instance, myofibroblasts have been shown to enhance epithelial cell proliferation and intestinal epithelial restitution \[[@B4]\]. In addition, microbiota have been shown to control both the maturation and the maintenance of the IEB \[[@B5]\].

The enteric nervous system (ENS) is also a major constituent of the cellular microenvironment of the IEB. Indeed IEB and, in particular, the proliferative compartment of the crypts are densely innervated by nerve fibres originating mainly from the submucosal plexus. Recent data have shown that, besides controlling secretory processes, activation of enteric neurons can reduce IEC proliferation and barrier permeability, in particular *via*the release of vasoactive intestinal peptide (VIP) \[[@B6]-[@B8]\]. Enteric neurons innervating the IEB are also closely associated with enteric glial cells (EGC), the major constituent of the ENS.

For many years, EGC have been considered as mainly passive and structural cells supporting neurons and ganglions. However, this concept has lately been revisited mainly focused on the role played by astrocytes in the central nervous system (CNS) \[[@B9]-[@B11]\]. Besides controlling and regulating neuronal functions, increasing evidence suggests that EGC could be major regulators of IEB functions, similar to astrocytes controlling blood brain barrier functions \[[@B10]\]. Supporting this concept, recent data have demonstrated that EGC can profoundly inhibit IEC proliferation, in part *via*the liberation of TGF-β1 \[[@B12]\]. EGC also decrease IEB paracellular permeability *via*the release of S-nitrosoglutathione (GSNO) \[[@B13]\]. Furthermore, *in vivo*lesions of EGC network increase IEB paracellular permeability and IEC proliferation and, at term, lead to major lethal intestinal inflammation \[[@B13]-[@B15]\]. However, the role of EGC in the control of other major IEC functions such as cell differentiation, cell-to-cell or cell-to-matrix adhesion, and the associated regulatory pathways remains largely unknown.

Therefore, in our study, we combined transcriptomic studies as well as functional studies to determine the impact of EGC on the regulation of major genes and functions involved in IEB homeostasis. Microarray approach was used to identify EGC-induced modifications in gene expression profiling of proliferating Caco-2. The identified genes and related functional pathways are consistent with the concept that EGC are a major constituent of the IEB microenvironment favoring barrier protection.

Results and Discussion
======================

Enteric glial cells modulate intestinal epithelial cells transcriptome
----------------------------------------------------------------------

### Microarray experiments

We performed microarray analysis of EGC influence on the transcriptome of Caco-2 cells using oligonucleotide chips (Cancerochips) developed at West Genopole transcriptome core facility of Nantes. These microarrays contain around 6,864 genes and are dedicated to gene expression studies in Caco-2 cell line as well as to gene expression signature studies of multiple tumors. Caco-2 cells were cultured onto Transwell filters in the absence or presence of EGC seeded at the bottom of the wells for 8 or 24 hours. The Transwell filters did not allowed any contact between IEC and EGC, thus implicating only paracrine communication between the two cell types.

Hierarchical clustering of the whole data showed the impact of the time of culture as well as the impact of the presence of EGC on the transcriptional profiling of IEC, i.e. Caco-2 cells (Figure [1](#F1){ref-type="fig"}). We observed changes in IEC transcriptome over the 24 hours of culture in control condition. At 8 hours, differences in transcriptome profiling already existed in control condition as compared to t = 0. In general, the observed changes in differentially expressed genes between t = 0 and t = 8 hours in control conditions were increased in the same way of regulation when reaching t = 24 hours (Figure [1](#F1){ref-type="fig"}). These changes might be due to the growth and differentiation of the proliferating IEC over the 24 hours of culture. We observed no major differences in gene expression profiling between IEC cultured alone and IEC cultured in presence of EGC at 8 hours of culture. In contrast, at 24 hours, EGC presence led to consistent and major changes in IEC gene expression profiling (Figure [1](#F1){ref-type="fig"}).

![**Hierarchical clustering of expression data**. Four individual microarrays were used per condition. Hierarchical clustering was performed on genes using Gene Cluster. Each ratio was normalized to the median of the t = 0 hour-condition values of the corresponding gene. Each column represents an individual array (T0: t = 0 hour condition samples; T8control: t = 8 hours of culture without EGC; T8glia: t = 8 hours of culture in presence of EGC; T24control: t = 24 hours of culture without EGC; T24glia: t = 24 hours of culture in presence of EGC). Each line represents one individual gene. The clustering shows the impact of the time of culture on gene expression profiling in Caco-2 cells. The EGC-induced modulation of IEC transcriptome is highly visible at t = 24 hours.](1471-2164-10-507-1){#F1}

### Gene expression modulated by EGC

Using Genespring software, we aimed to identify statistically significant differences in gene expression profiling between Caco-2 cells cultured alone or in presence of EGC. After 8 h of culture, no significant difference in gene expression profiling was found between IEC cultured alone (control condition) or in presence of EGC (\"glia\" condition). However, after 24 hours of culture, we identified 116 genes differentially expressed between control and EGC conditions by using two different strategies. Benjamini and Hochberg False Discovery Rate method was used to determine 98 differentially expressed genes between control and glia conditions at t = 24 hours, and we also selected 27 genes with a two-fold change and Student\'s t-test p-value less than or equal to 0.05. Among the 116 differentially expressed genes, 46 genes were down-regulated and 70 were up-regulated in IEC cultured with EGC as compared to control (Table [1](#T1){ref-type="table"}, [2](#T2){ref-type="table"}). Quantitative PCR was also performed on various genes to validate the microarray results. In particular, results showed an EGC-induced increase of *CDH1, FN1*, *LAMA5*, *PPARG, PTK2*mRNA expression in IEC and a decrease of *E2F1, FGFR2, GPX2*and *SMAD3*mRNA expression in IEC, similar to the data obtained with microarrays (Figure [2A](#F2){ref-type="fig"}). We next sought to determine the specificity of EGC effects upon IEC transcriptome by characterizing the impact of fibroblasts on the expression of these genes in IEC. Under identical culture conditions, we showed that fibroblasts increased expression of *PTK2*but did not significantly modify gene expression of *CDH1, FN1*, *LAMA5*, *PPARG, E2F1, GPX2 and SMAD3*in IEC (Figure [2B](#F2){ref-type="fig"}).

###### 

List of the genes up-regulated by enteric glial cells in intestinal epithelial cells.

  Gene Symbol   Genbank                                         Description                                                                                         \% up-regulation (/control)   Fold difference
  ------------- ----------------------------------------------- --------------------------------------------------------------------------------------------------- ----------------------------- -----------------
  TXNIP         [NM_006472](NM_006472)                          thioredoxin interacting protein                                                                     217,60                        3,18
  ANKRD1        [NM_014391](NM_014391)                          ankyrin repeat domain 1 (cardiac muscle)                                                            169,22                        2,69
  FN1           [U42593](U42593)                                fibronectin 1                                                                                       152,16                        2,52
  TUBB3         [NM_006086](NM_006086)                          tubulin, beta 3                                                                                     149,94                        2,50
  MGLL          [AJ270950](AJ270950)                            monoglyceride lipase                                                                                135,97                        2,36
  METTL7A       [NM_014033](NM_014033)                          methyltransferase like 7A                                                                           132,96                        2,33
  PKN2          [NM_006256](NM_006256)                          protein kinase N2                                                                                   128,33                        2,28
  /             [XM_166201](XM_166201)                          synonyms: KIAA0056, MGC104671; Homo sapiens KIAA0056 protein (hCAP-D3), mRNA.                       115,09                        2,15
  EPB41L2       [NM_001431](NM_001431)                          erythrocyte membrane protein band 4.1-like 2                                                        110,50                        2,11
  AASS          [AJ007714](AJ007714)                            aminoadipate-semialdehyde synthase                                                                  110,15                        2,10
  ACTG2         [NM_001615](NM_001615)                          actin, gamma 2, smooth muscle, enteric                                                              102,56                        2,03
  B4GALT5       [NM_004776](NM_004776)                          UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 5                                   102,38                        2,02
  SNX2          [NM_003100](NM_003100)                          sorting nexin 2                                                                                     102,38                        2,02
  VIP           [NM_003381](NM_003381)                          vasoactive intestinal peptide                                                                       102,33                        2,02
  EIF4A2        [NM_001967](NM_001967)                          eukaryotic translation initiation factor 4A, isoform 2                                              102,14                        2,02
  /             [NM_019027](NM_019027)                          RNA-binding protein                                                                                 101,66                        2,02
  POLR3F        [NM_006466](NM_006466)                          polymerase (RNA) III (DNA directed) polypeptide F, 39 kDa                                           94,46                         1,94
  PNRC1         [NM_006813](NM_006813)                          proline-rich nuclear receptor coactivator 1                                                         93,24                         1,93
  NPPB          [NM_002521](NM_002521)                          natriuretic peptide precursor B                                                                     83,97                         1,84
  /             [BC017857](BC017857)                            Homo sapiens cDNA clone IMAGE:4690793, with apparent retained intron.                               82,20                         1,82
  KRT8          [NM_002273](NM_002273)                          keratin 8                                                                                           81,96                         1,82
  SAT1          [NM_002970](NM_002970)                          spermidine/spermine N1-acetyltransferase 1                                                          80,24                         1,80
  ASS1          [NM_000050](NM_000050)                          argininosuccinate synthetase 1                                                                      76,73                         1,77
  S100A11P      [NM_021039](NM_021039)                          /                                                                                                   75,22                         1,75
  SLC7A7        [NM_003982](NM_003982)                          solute carrier family 7 (cationic amino acid transporter, y+ system), member 7                      72,31                         1,72
  HAGH          [NM_005326](NM_005326)                          hydroxyacylglutathione hydrolase                                                                    69,54                         1,70
  BNIP3L        [AF536326](AF536326)                            BCL2/adenovirus E1B 19 kDa interacting protein 3-like                                               69,19                         1,69
  /             [AF195968](AF195968)                            PRR5-ARHGAP8 fusion                                                                                 68,01                         1,68
  BNIP3         [NM_004052](NM_004052)                          BCL2/adenovirus E1B 19 kDa interacting protein 3                                                    67,84                         1,68
  IL18          [NM_001562](NM_001562)                          interleukin 18 (interferon-gamma-inducing factor)                                                   67,14                         1,67
  RDM1          [BC038301](BC038301)                            RAD52 motif 1                                                                                       67,11                         1,67
  FAM107B       [NM_031453](NM_031453)                          family with sequence similarity 107, member B                                                       65,70                         1,66
  PLAC8         [NM_016619](NM_016619)                          placenta-specific 8                                                                                 63,77                         1,64
  SMARCA1       [NM_139035](NM_139035)                          SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 1   63,72                         1,64
  PLOD2         [NM_000935](NM_000935)                          procollagen-lysine, 2-oxoglutarate 5-dioxygenase 2                                                  62,87                         1,63
  TMSB4Y        [NM_004202](NM_004202)                          thymosin, beta 4, Y-linked                                                                          62,77                         1,63
  SCPEP1        [NM_021626](NM_021626)                          serine carboxypeptidase 1                                                                           60,96                         1,61
  LAMA5         [NM_005560](NM_005560)                          laminin, alpha 5                                                                                    60,53                         1,61
  LAMC1         [NM_002293](NM_002293)                          laminin, gamma 1 (formerly LAMB2)                                                                   59,89                         1,60
  METAP1        [BC030054](BC030054)                            methionyl aminopeptidase 1                                                                          59,55                         1,60
  IQGAP2        [NM_006633](NM_006633)                          IQ motif containing GTPase activating protein 2                                                     58,98                         1,59
  C1orf43       [NM_015449](NM_015449)                          chromosome 1 open reading frame 43                                                                  56,86                         1,57
  CASP4         [NM_001225](NM_001225)                          caspase 4, apoptosis-related cysteine peptidase                                                     55,71                         1,56
  BTG1          [NM_001731](NM_001731)                          B-cell translocation gene 1, anti-proliferative                                                     54,63                         1,55
  SLC2A1        [K03195](K03195)                                solute carrier family 2 (facilitated glucose transporter), member 1                                 54,34                         1,54
  DCTN2         [NM_006400](NM_006400)                          dynactin 2 (p50)                                                                                    52,68                         1,53
  TOP2A         [NM_001067](NM_001067)                          topoisomerase (DNA) II alpha 170 kDa                                                                52,42                         1,52
  KRT18         [NM_000224](NM_000224)                          keratin 18                                                                                          51,16                         1,51
  LAMC1         [M55210](M55210)                                laminin, gamma 1 (formerly LAMB2)                                                                   50,37                         1,50
  PRC1          [BC005140](BC005140)                            protein regulator of cytokinesis 1                                                                  50,13                         1,50
  IMPDH2        [NM_000884](NM_000884)                          IMP (inosine monophosphate) dehydrogenase 2                                                         49,46                         1,49
  /             [AF202922](AF202922)                            LRP16 protein                                                                                       48,20                         1,48
  PLD3          [NM_012268](NM_012268)                          phospholipase D family, member 3                                                                    46,99                         1,47
  RNF4          [NM_002938](NM_002938)                          ring finger protein 4                                                                               44,88                         1,45
  /             [AC060225](AC060225)                            Homo sapiens 3 BAC RP11-23J16 complete sequence.                                                    42,10                         1,42
  SMARCA1       [NM_003069](NM_003069)                          SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 1   41,18                         1,41
  DYNLT3        [NM_006520](NM_006520)                          dynein, light chain, Tctex-type 3                                                                   40,06                         1,40
  PPARG         [NM_015869](NM_015869)                          peroxisome proliferative activated receptor, gamma                                                  38,92                         1,39
  GLRX          [AF069668](AF069668)                            glutaredoxin (thioltransferase)                                                                     37,78                         1,38
  PTK2          [NM_153831](NM_153831);[NM_005607](NM_005607)   PTK2 protein tyrosine kinase 2                                                                      37,72                         1,38
  CDH1          [NM_004360](NM_004360)                          cadherin 1, type 1, E-cadherin (epithelial)                                                         36,87                         1,37
  RNASE4        [NM_002937](NM_002937)                          ribonuclease, RNase A family, 4                                                                     31,40                         1,31
  CTSH          [NM_004390](NM_004390)                          cathepsin H                                                                                         29,45                         1,29
  MKI67         [NM_002417](NM_002417)                          antigen identified by monoclonal antibody Ki-67                                                     29,28                         1,29
  EIF2A         [NM_032025](NM_032025)                          eukaryotic translation initiation factor 2A, 65 kDa                                                 26,54                         1,27
  TGFBI         [BC000097](BC000097)                            transforming growth factor, beta-induced, 68 kDa                                                    25,95                         1,26
  MLLT3         [NM_004529](NM_004529)                          myeloid/lymphoid or mixed-lineage leukemia (trithorax homolog, Drosophila); translocated to, 3      22,42                         1,22
  APOBEC3B      [NM_004900](NM_004900)                          apolipoprotein B mRNA editing enzyme, catalytic polypeptide-like 3B                                 22,20                         1,22
  ADD3          [NM_019903](NM_019903)                          adducin 3 (gamma)                                                                                   20,82                         1,21
  FTH1          [NM_002032](NM_002032)                          ferritin, heavy polypeptide 1                                                                       15,97                         1,16

###### 

List of the genes down-regulated by enteric glial cells in intestinal epithelial cells.

  Gene Symbol   Genbank                        Description                                                                                \% down-regulation (/control)   Fold difference
  ------------- ------------------------------ ------------------------------------------------------------------------------------------ ------------------------------- -----------------
  CARD12        [AF376061](AF376061)           caspase recruitment domain family, member 12                                               83,43                           6,04
  KLK14         [NM_022046](NM_022046)         kallikrein 14                                                                              62,46                           2,66
  FGFR2         [NM_022970](NM_022970)         fibroblast growth factor receptor 2                                                        57,12                           2,33
  BDP1          [NM_018429](NM_018429)         B double prime 1, subunit of RNA polymerase III transcription initiation factor IIIB       56,58                           2,30
  SFRP4         [NM_003014](NM_003014)         secreted frizzled-related protein 4                                                        55,26                           2,24
  C6            [NM_000065](NM_000065)         complement component 6                                                                     54,78                           2,21
  PRKCD         [NM_006254](NM_006254)         protein kinase C, delta                                                                    54,67                           2,21
  /             [XM_066534](XM_066534)         Homo sapiens diacylglycerol kinase, kappa (DGKK), mRNA.                                    52,44                           2,10
  C20orf133     [NM_001033086](NM_001033086)   chromosome 20 open reading frame 133                                                       52,36                           2,10
  PRKCQ         [NM_006257](NM_006257)         protein kinase C, theta                                                                    50,50                           2,02
  CDK5R1        [NM_003885](NM_003885)         cyclin-dependent kinase 5, regulatory subunit 1 (p35)                                      50,42                           2,02
  RPP40         [NM_006638](NM_006638)         ribonuclease P 40 kDa subunit                                                              47,41                           1,90
  SLC30A1       [AF323590](AF323590)           solute carrier family 30 (zinc transporter), member 1                                      46,22                           1,86
  TIMM8A        [NM_004085](NM_004085)         translocase of inner mitochondrial membrane 8 homolog A (yeast)                            41,07                           1,70
  EBNA1BP2      [NM_006824](NM_006824)         EBNA1 binding protein 2                                                                    36,39                           1,57
  ITGAE         [NM_002208](NM_002208)         integrin, alpha E (antigen CD103, human mucosal lymphocyte antigen 1; alpha polypeptide)   36,17                           1,57
  NOL1          [NM_006170](NM_006170)         nucleolar protein 1, 120 kDa                                                               33,86                           1,51
  C6orf66       [NM_014165](NM_014165)         chromosome 6 open reading frame 66                                                         33,81                           1,51
  NOL5A         [NM_006392](NM_006392)         nucleolar protein 5A (56 kDa with KKE/D repeat)                                            33,30                           1,50
  BAG1          [U46917](U46917)               BCL2-associated athanogene                                                                 32,19                           1,47
  /             [AF123534](AF123534)           nucleolar protein NOP5/NOP58                                                               32,14                           1,47
  ASAH1         [AK025211](AK025211)           N-acylsphingosine amidohydrolase (acid ceramidase) 1                                       29,98                           1,43
  TINAGL1       [AF236150](AF236150)           tubulointerstitial nephritis antigen-like 1                                                29,62                           1,42
  AADAC         [NM_001086](NM_001086)         arylacetamide deacetylase (esterase)                                                       29,48                           1,42
  HSPA14        [AF112210](AF112210)           heat shock 70 kDa protein 14                                                               29,34                           1,42
  PSMC6         [NM_002806](NM_002806)         proteasome (prosome, macropain) 26S subunit, ATPase, 6                                     29,31                           1,41
  HNRPDL        [D89678](D89678)               heterogeneous nuclear ribonucleoprotein D-like                                             28,40                           1,40
  SAMHD1        [NM_015474](NM_015474)         SAM domain and HD domain 1                                                                 28,12                           1,39
  TP53RK        [NM_033550](NM_033550)         TP53 regulating kinase                                                                     26,99                           1,37
  MARK2         [NM_004954](NM_004954)         MAP/microtubule affinity-regulating kinase 2                                               26,41                           1,36
  CCR9          [NM_031200](NM_031200)         chemokine (C-C motif) receptor 9                                                           24,74                           1,33
  RGL1          [NM_015149](NM_015149)         ral guanine nucleotide dissociation stimulator-like 1                                      24,20                           1,32
  E2F1          [NM_005225](NM_005225)         E2F transcription factor 1                                                                 23,90                           1,31
  PSMC1         [NM_002802](NM_002802)         proteasome (prosome, macropain) 26S subunit, ATPase, 1                                     23,75                           1,31
  IMP3          [NM_018285](NM_018285)         IMP3, U3 small nucleolar ribonucleoprotein, homolog (yeast)                                23,48                           1,31
  RNU3IP2       [BC023662](BC023662)           RNA, U3 small nucleolar interacting protein 2                                              23,41                           1,31
  SMAD3         [NM_005902](NM_005902)         SMAD, mothers against DPP homolog 3 (Drosophila)                                           21,49                           1,27
  GPX2          [NM_002083](NM_002083)         glutathione peroxidase 2 (gastrointestinal)                                                21,27                           1,27
  LSP1          [NM_002339](NM_002339)         lymphocyte-specific protein 1                                                              21,21                           1,27
  FGG           [NM_021870](NM_021870)         fibrinogen gamma chain                                                                     18,37                           1,23
  C20orf94      [NM_001009608](NM_001009608)   chromosome 20 open reading frame 94                                                        16,04                           1,19
  PPIL1         [NM_016059](NM_016059)         peptidylprolyl isomerase (cyclophilin)-like 1                                              14,74                           1,17
  HOXB2         [NM_002145](NM_002145)         homeobox B2                                                                                13,91                           1,16
  APOH          [NM_000042](NM_000042)         apolipoprotein H (beta-2-glycoprotein I)                                                   13,17                           1,15
  PRSS23        [NM_007173](NM_007173)         protease, serine, 23                                                                       10,41                           1,12
  IARS2         [NM_018060](NM_018060)         isoleucine-tRNA synthetase 2, mitochondrial                                                10,02                           1,11

![**Enteric glial cells EGC) and fibroblasts differentially modulated intestinal epithelial cell (IEC) transcriptome**. (A). Real-time quantitative PCR studies on *CDH1*(n = 5), *FN1*(n = 7), *LAMA5*(n = 6), *PPARG*(n = 5), *PTK2*(n = 5), *E2F1*(n = 7), *FGFR2*(n = 6), *GPX2*(n = 8), *SMAD3*(n = 7) gene expression in IEC cultured for 24 hours alone (- EGC) or in presence of EGC(+ EGC) confirmed that EGC significantly modulate the level of expression of genes identified by the microarrays data analysis as differentially expressed in IEC cultured in presence of EGC (\*p \< 0.05; Mann-Whitney test). (B). In contrast, real-time quantitative PCR studies on *CDH1*(n = 5), *FN1*(n = 5), *LAMA5*(n = 5), *PPARG*(n = 5), *PTK2*(n = 5), *E2F1*(n = 5), *GPX2*(n = 5), *SMAD3*(n = 5) gene expression in IEC cultured for 24 hours alone (- fibroblasts) or in presence of fibroblasts (+fibroblasts) showed a differential regulation of gene expression as compared to EGC effects (\*p \< 0.05; Mann-Whitney test).](1471-2164-10-507-2){#F2}

### Hierarchical clustering of differentially expressed genes

Hierarchical clustering was used to visualize the expression profile of the 116 genes induced or repressed by EGC after 24 hours of culture (Figure [3](#F3){ref-type="fig"}).

![**Hierarchical clustering of the 116 identified genes expression data**. Four individual microarrays were used per condition. Hierarchical clustering was performed on conditions and on the 116 genes identified with Genespring. Each ratio was normalized to the median of the t = 0 hour-condition values of the corresponding gene. Each column represents an individual array (T0: t = 0 hour condition samples; T8control: t = 8 hours of culture without EGC; T8glia: t = 8 hours of culture in presence of EGC; T24control: t = 24 hours of culture without EGC; T24glia: t = 24 hours of culture in presence of EGC). Each line represents one individual gene. The clustering reveals clusters of genes with similar pattern of expression among the different conditions. The cluster also shows the distance between the five conditions demonstrating major changes induced by the culture with EGC at t = 24 hours.](1471-2164-10-507-3){#F3}

All these genes exhibit a differential expression between control and EGC conditions at t = 24 hours. Furthermore, some of them already exhibited a slight difference in expression profile between control and EGC conditions at 8 hours. These results indicate that EGC effects on genes identified as differentially expressed in IEC at 24 hours probably started as early as at 8 hours, even though the modifications were not statistically significant.

Two groups of samples exhibited a very different profile from other samples: EGC condition at t = 24 hours and controls at t = 24 hours (Figure [3](#F3){ref-type="fig"}). These observations confirm that 1) no major changes existed between control and EGC conditions at t = 8 hours and 2) that the 24 hour-time of culture impacted on gene expression profiling in IEC, likely reflecting differentiation of IEC over the time of culture.

EGC regulate IEC functions
--------------------------

### Gene network interactions

Biological interactions among the 116 genes of the gene set provided by Genespring analysis were identified using Ingenuity Pathways Analysis. Among the 116 genes differentially expressed, Ingenuity identified 92 genes contributing to a total of 10 functional networks (Table [3](#T3){ref-type="table"}). Each of the 6 first networks contained at least 14 genes that were associated with cell-to-cell signalling and interaction, cellular growth and proliferation, cell morphology, cellular movement, cell death and cell cycle. The 116 genes were also classified into Ingenuity cellular and molecular pathways as well as into Ingenuity signalling pathways (Table [4](#T4){ref-type="table"} and [5](#T5){ref-type="table"}). All the functions described above and identified by building functional networks among our gene set were found in the 25 cellular and molecular functions obtained with Ingenuity (Table [4](#T4){ref-type="table"}). Moreover, these 6 functions were among the 10 first functions presenting the highest score (Table [4](#T4){ref-type="table"}). Finally, the signalling pathways identified by the Ingenuity analysis of our gene set were also relevant to those 6 functions (Table [5](#T5){ref-type="table"}). The limit of Ingenuity analysis for our study is that it is not restricted to one specific organ or cell, so that all the results of Ingenuity analysis could not be transposed directly to the regulation of IEC functions by EGC. We therefore performed an \"epithelial\" specific analysis of the major functions identified with Ingenuity.

###### 

Lists of differentially expressed genes involved in functional networks regulated in intestinal epithelial cells by enteric glial cells.

  -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Ingenuity^©^top functions                                 Genes list                                                                                                                            Score
  --------------------------------------------------------- ------------------------------------------------------------------------------------------------------------------------------------- -------
  Cell-To-Cell Signaling and Interaction\                   CDH1, FN1, ITGAE, KRT8, KRT18, MGLL, NPPB, PKN2, PPARG, PRKCD, PSMC1, PSMC6, PTK2, SAT, SMAD3, TGFBI, VIP                             26
  Cell Morphology\                                                                                                                                                                                
  Tissue Development                                                                                                                                                                              

                                                                                                                                                                                                  

  Cellular Growth and Proliferation\                        B4GALT5, BAG1, BNIP3 (includes EG:664), CCR9, DCTN2, EBNA1BP2, HCAP-D3, LSP1, MLLT3, PNRC1, PPIL1, PRC1, RNF4, SAT, SLC30A1, TP53RK   24
  Cancer\                                                                                                                                                                                         
  Gene Expression                                                                                                                                                                                 

                                                                                                                                                                                                  

  Cell Morphology\                                          AASS, ACTG2, BNIP3L, BTG1, CTSH, DYNLT3, EIF4A2, GLRX, MKI67, PLOD2, RNASE4, SLC2A1, SLC7A7, TXNIP                                    20
  Cellular Development\                                                                                                                                                                           
  Cardiovascular System Development and Function                                                                                                                                                  

                                                                                                                                                                                                  

  Cellular Movement\                                        APOBEC3B, ASAH1, C6, FTH1, IL18, IQGAP2, LAMA5, LAMC1, NOL5A, NOP5/NOP58, PLD3, PRKCQ, PRSS23, SCPEP1                                 20
  Hematological System Development and Function\                                                                                                                                                  
  Immune Response                                                                                                                                                                                 

                                                                                                                                                                                                  

  Cell Death\                                               APOH, ASS, BDP1, BTG1, CARD12, CASP4, E2F1, FGFR2, FGG, NOL1, RGL1, SMARCA1, SNX2, TOP2A                                              20
  Cancer\                                                                                                                                                                                         
  Gastrointestinal Disease                                                                                                                                                                        

                                                                                                                                                                                                  

  Cell Cycle\                                               ADD3, ANKRD1, CDK5R1, EPB41L2, GPX2, HNRPDL, HOXB2, IMPDH2, MARK2, PKN2, PLAC8, POLR3F, SFRP4, TUBB3                                  20
  Gastrointestinal Disease\                                                                                                                                                                       
  Developmental Disorder                                                                                                                                                                          

                                                                                                                                                                                                  

  RNA Post-Transcriptional Modification                     IMP3                                                                                                                                  2

                                                                                                                                                                                                  

  RNA Post-Transcriptional Modification                     EIF2A                                                                                                                                 2

                                                                                                                                                                                                  

  Protein Trafficking\                                      TIMM8A                                                                                                                                1
  Cellular Compromise\                                                                                                                                                                            
  Auditory and Vestibular System Development and Function                                                                                                                                         

                                                                                                                                                                                                  

  RNA Post-Transcriptional Modification\                    RPP40                                                                                                                                 1
  RNA Damage and Repair                                                                                                                                                                           
  -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

###### 

Lists of differentially expressed genes involved in cellular and molecular functions regulated in intestinal epithelial cells by enteric glial cells.

  Ingenuity^©^cellular and molecular functions   Genes list                                                                                                                                                                                                                                                              Score
  ---------------------------------------------- ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- -------
  RNA Post-Transcriptional Modification          NOP5/NOP58, NOL5A, EBNA1BP2, RNU3IP2, IMP3                                                                                                                                                                                                                              5.17
  Cell Death                                     GPX2, SAT, PRKCD, B4GALT5, TXNIP, TOP2A, CDH1, PKN2, ASAH1, LSP1, BNIP3L, NPPB, CDK5R1, ANKRD1, VIP, CASP4, GLRX, FGFR2, KRT18, BAG1, PRKCQ, BTG1, PPARG, C6ORF66, SLC2A1, CARD12, SMAD3, FTH1, LAMA5, PTK2, IL18, MLLT3, FN1, PLAC8, KRT8, TGFBI, BNIP3, E2F1, SFRP4   4.85
  Cell-To-Cell Signaling and Interaction         APOH, PRKCD, SMAD3, CDH1, PKN2, LAMA5, PTK2, VIP, IL18, FN1, FGG, KRT8, KRT18, BAG1, ITGAE, LAMC1, PPARG, TGFBI, E2F1                                                                                                                                                   3.92
  Cellular Development                           SMAD3, PRKCD, CDH1, LAMA5, VIP, PTK2, IL18, CDK5R1, FGFR2, FN1, PLAC8, PRKCQ, LAMC1, PPARG, E2F1                                                                                                                                                                        3.92
  Cell Morphology                                SMAD3, PRKCD, CDH1, LAMA5, LSP1, DCTN2, VIP, IL18, PTK2, CDK5R1, FN1, KRT8, KRT18, PPARG, TGFBI, E2F1                                                                                                                                                                   3.88
  Cellular Assembly and Organization             APOH, PRKCD, SMAD3, TOP2A, CDH1, DCTN2, EBNA1BP2, NPPB, PTK2, CDK5R1, HCAP-D3, FN1, FGG, KRT8, KRT18, MARK2, LAMC1, PPARG, BNIP3, E2F1                                                                                                                                  3.88
  Carbohydrate Metabolism                        FN1, B4GALT5, NPPB, PTK2, IL18                                                                                                                                                                                                                                          3.11
  Cellular Movement                              HOXB2, CCR9, C6, B4GALT5, SMAD3, PRKCD, MGLL, CDH1, LSP1, LAMA5, DCTN2, NPPB, CDK5R1, VIP, PTK2, IL18, FN1, BAG1, ITGAE, PPARG, TGFBI                                                                                                                                   3.08
  Cellular Growth and Proliferation              SAT, PRKCD, TXNIP, SMAD3, CDH1, FTH1, LAMA5, SLC30A1, EBNA1BP2, VIP, IL18, PTK2, MLLT3, FGFR2, FN1, PLAC8, BAG1, PRKCQ, BTG1, LAMC1, PPARG, BNIP3, E2F1, SFRP4                                                                                                          3.05
  Cell Cycle                                     HCAP-D3, FN1, TXNIP, PRKCD, TOP2A, DCTN2, PPARG, EBNA1BP2, E2F1, VIP                                                                                                                                                                                                    2.57
  Molecular Transport                            FGFR2, SAT, FN1, PRKCD, MGLL, BAG1, FTH1, PPARG, NPPB, PTK2, VIP, IL18                                                                                                                                                                                                  2.45
  Nucleic Acid Metabolism                        SAT, BAG1, NPPB, VIP                                                                                                                                                                                                                                                    2.45
  Small Molecule Biochemistry                    APOH, SAT, PRKCD, B4GALT5, MGLL, FTH1, ASAH1, NPPB, PTK2, IL18, VIP, ASS, GLRX, FGFR2, FN1, BAG1, PPARG                                                                                                                                                                 2.45
  Cellular Function and Maintenance              CCR9, SMAD3, CDH1, SLC30A1, PTK2, IL18, CDK5R1, FN1, FGG, KRT18, ITGAE, PPARG, BNIP3                                                                                                                                                                                    2.25
  DNA Replication, Recombination, and Repair     HCAP-D3, FN1, SMAD3, PRKCD, TOP2A, FTH1, DCTN2, EBNA1BP2                                                                                                                                                                                                                2.17
  Gene Expression                                APOH, SMAD3, PRKCD, CDH1, PKN2, VIP, IL18, FN1, BAG1, PRKCQ, RNF4, PPARG, E2F1                                                                                                                                                                                          2.13
  Cell Signaling                                 ASS, FN1, PRKCD, PPARG                                                                                                                                                                                                                                                  2.02
  Amino Acid Metabolism                          ASS, FTH1                                                                                                                                                                                                                                                               1.94
  Cellular Compromise                            PRKCD, KRT18, TIMM8A, PPARG, E2F1                                                                                                                                                                                                                                       1.94
  Drug Metabolism                                GLRX, FTH1, NPPB, IL18, VIP                                                                                                                                                                                                                                             1.94
  Lipid Metabolism                               FGFR2, APOH, SAT, FN1, MGLL, ASAH1, PPARG, NPPB, VIP                                                                                                                                                                                                                    1.94
  Post-Translational Modification                PRKCD, BAG1, PRKCQ                                                                                                                                                                                                                                                      1.94
  Protein Folding                                BAG1                                                                                                                                                                                                                                                                    1.94
  Protein Synthesis                              BAG1, IL18                                                                                                                                                                                                                                                              1.94
  Vitamin and Mineral Metabolism                 FGFR2, FTH1, PPARG                                                                                                                                                                                                                                                      1.94

###### 

Lists of differentially expressed genes involved in signalling pathways regulated in intestinal epithelial cells by enteric glial cells.

  Ingenuity^©^Signalling Pathway                      Genes                                     Ratio
  --------------------------------------------------- ----------------------------------------- -------
  Circadian Rhythm Signaling                          VIP                                       0.046
  Cell Cycle: G1/S Checkpoint Regulation              SMAD3, E2F1                               0.041
  Integrin Signaling                                  ACTG2, FN1, LAMA5, LAMC1, PTK2            0.03
  Actin Cytoskeleton Signaling                        TMSB4Y, FGFR2, FN1, ITGAE, IQGAP2, PTK2   0.029
  Cell Cycle: G2/M DNA Damage Checkpoint Regulation   TOP2A                                     0.029
  VEGF Signaling                                      ACTG2, PTK2                               0.029
  Complement and Coagulation Cascades                 FGG, C6                                   0.028
  Amyloid Processing                                  CDK5R1                                    0.028
  ERK/MAPK Signaling                                  PRKCD, PPARG, PTK2                        0.024
  Wnt/β-catenin Signaling                             CDH1, MARK2, SFRP4                        0.022
  FGF Signaling                                       FGFR2                                     0.018
  Chemokine Signaling                                 PTK2                                      0.018
  TGF-β Signaling                                     SMAD3                                     0.016
  Protein Ubiquitination Pathway                      PSMC6, PSMC1, BAG1                        0.016
  PPAR Signaling                                      PPARG                                     0.015
  IGF-1 Signaling                                     PTK2                                      0.015
  Apoptosis Signaling                                 PRKCQ                                     0.015
  Neuregulin Signaling                                CDK5R1                                    0.015
  PTEN Signaling                                      PTK2                                      0.014
  Fc Epsilon RI Signaling                             PRKCD                                     0.014
  T Cell Receptor Signaling                           PRKCQ                                     0.014
  Xenobiotic Metabolism Signaling                     PRKCD, PRKCQ                              0.010
  NF-κB Signaling                                     PRKCQ                                     0.009
  B Cell Receptor Signaling                           PRKCQ                                     0.009
  Ephrin Receptor Signaling                           PTK2                                      0.009
  Leukocyte Extravasation Signaling                   PTK2                                      0.008
  Huntington\'s Disease Signaling                     CDK5R1                                    0.007
  Axonal Guidance Signaling                           PTK2                                      0.004

### Cell-to cell and cell-to-matrix interaction

EGC regulated the expression of numerous genes involved in the control of IEC adhesive processes. In particular, EGC induced an up-regulation of the expression of all 7 genes with pro-adhesive functions and a down-regulation of the 2 genes with anti adhesive properties, among the gene set found to be differentially expressed in IEC cultured in presence of EGC (Table [6](#T6){ref-type="table"}). These genes are crucially involved in the control of cell-to-cell and cell-to-matrix adhesion.

###### 

Genes controlling intestinal epithelial cells adhesion and modulated by enteric glial cells.

  Pro-adhesive      Anti-adhesive                                                
  ----------------- ------------------------------------------ ----------------- ------------------------------------------
  **Gene Symbol**   **Regulation of gene expression by EGC**   **Gene Symbol**   **Regulation of gene expression by EGC**
  CDH1              up-regulated                               CDK5R1            down-regulated
  IQGAP2            up-regulated                               KLK14             down-regulated
  LAMA5             up-regulated                                                 
  LAMC1             up-regulated                                                 
  FN1               up-regulated                                                 
  PTK2              up-regulated                                                 
  KRT8              up-regulated                                                 

First, EGC concomitantly increased the expression of *CDH-1*, which encodes E-cadherin, and decreased the expression of *CDK5R1*. E-Cadherin is the major component of the adherent junction complexes and the level of E-Cadherin in IEC is to be correlated to adhesion complexes formation between IEC \[[@B16],[@B17]\]. Further evidences confirming a pro-adhesive influence of EGC on IEC is the EGC-induced down-regulation of *CDK5R1*expression. Indeed, *CDK5R1*encodes p35, a regulator of CDK-5 (cyclin-dependent kinase), which induces the degradation of E-Cadherin precursor \[[@B18]\]. In addition, EGC also up-regulated *IQGAP2*expression in IEC. This gene encodes for a protein member of IQGAP family that interacts with several molecules controlling cytoskeleton organization, cell adhesion and cell motility such as CDC42 and Rac \[[@B19]\]. Interestingly, IQGAP2 has been shown to mediate E-Cadherin-based cell-to-cell adhesion during development \[[@B20]\]. All these results suggest that EGC enhance cell-to-cell adhesion in IEC.

Our data also demonstrate that EGC modulate the expression of genes that are involved in cell-to-matrix interactions. First, EGC increased expression of several genes encoding proteins of the extracellular matrix such as *LAMA5*, *LAMC1*and *FN1*. *LAMA5*and *LAMC1*encode respectively for laminin α5 and γ1 chains which, together with laminin β1 chain, compose laminin-10 \[[@B21]\]. Laminin-10 has been shown to be the most adhesive substratum of laminin isoforms when studying abilities of laminin-2,-5 and -10 in modulating Caco-2 cell adhesion \[[@B22]\]. Furthermore, EGC up-regulated *FN1*expression, encoding the fibronectin protein. Interestingly, fibronectin has recently been shown to enhance Caco-2 cell attachment and wound healing \[[@B23]\]. EGC down-regulated *KLK14*expression, which encodes KLK (kallikrein) 14, an extracellular serine protease which has been shown to cleave and digest various extracellular matrix proteins such as collagen IV, laminin and fibronectin \[[@B24]\]. In addition, EGC up-regulated *PTK2*expression in IEC which may result in increased expression of FAK (Focal Adhesion Kinase) protein, a major regulator of focal adhesions turnover and maturation \[[@B25]\]. Finally, EGC induced an up-regulation of *KRT8*expression whose increased expression has recently been shown to cause enhanced adhesion of human breast tumor cells to their extracellular matrix \[[@B26]\].

In conclusion, our data suggest that EGC regulation of IEC transcriptome leads to an increase in cell adhesion. In order to functionally validate this hypothesis, we performed *in vitro*experiments using established adhesion assays. Under these conditions, we first showed that IEC global adhesion was increased after 24 hours of culture with EGC as compared to control (Figure [4A](#F4){ref-type="fig"}). We next confirmed whether these effects were in part associated with an increase in cell-to-matrix adhesion as the majority of IEC genes regulated by EGC presence appeared to favor cell-to-matrix adhesion. Indeed, cell-to-matrix adhesion assays revealed that EGC significantly increased IEC adhesion to the filter as compared to control (Figure [4B](#F4){ref-type="fig"}).

![**Enteric glial cells (EGC) induced an increase in intestinal epithelial cells(IEC) adhesion**. (A):EGC induced a significant increase in IEC total adhesion (i.e. without discriminating cell-to-matrix and cell-to-cell adhesion) after 24 hours of co-culture in presence of EGC (+ EGC) as compared to control (- EGC) (n = 5; p = 0.008; Mann-Whitney test). (B): IEC were significantly more attached to their matrix when they were cultured for 24 hours with EGC (+ EGC) as compared to control (- EGC) (n = 13; p \< 0.001; Mann-Whitney test).](1471-2164-10-507-4){#F4}

### Cell differentiation

EGC also regulated the expression of numerous genes involved in IEC differentiation. In particular, EGC up-regulated the expression of 6 genes enhancing differentiation and down-regulated 3 genes known to inhibit IEC differentiation (Table [7](#T7){ref-type="table"}).

###### 

Genes controlling intestinal epithelial cells differentiation and modulated by enteric glial cells.

  Pro-differentiative   Anti-differentiative                                         
  --------------------- ------------------------------------------ ----------------- ------------------------------------------
  **Gene Symbol**       **Regulation of gene expression by EGC**   **Gene Symbol**   **Regulation of gene expression by EGC**
  CDH1                  up-regulated                               E2F1              down-regulated
  PPARG                 up-regulated                               BAG1              down-regulated
  LAMA5                 up-regulated                               CDK5R1            down-regulated
  PTK2                  up-regulated                               FN1               up-regulated
  DCTN2                 up-regulated                                                 
  DYNLT3                up-regulated                                                 

EGC induced an up-regulation of the expression of pro-differentiative genes or genes associated with enhanced differentiation of IEC such as *PPARG*, *LAMA5*, *PTK2*, *CDH-1, DCTN2*and *DYNLT3*. Indeed, PPARγ, encoding the well-described nuclear receptor superfamily member peroxisome proliferator-activated receptor gamma (PPAR-γ) has been shown to regulate IEC differentiation and its expression has been positively correlated with level of differentiation of Caco-2 and HT29 cells \[[@B27],[@B28]\]. Moreover, a diminution of laminin-a5 in a murine model resulted in a transformation from a small intestinal to a colonic mucosal architecture, suggesting that laminin-α5 has a crucial role in establishing and maintaining the architecture of the small intestine \[[@B29]\]. In addition, it has already been shown that the differentiation of Caco-2 cells was accompanied by an increase in FAK expression \[[@B30]\]. E-Cadherin, whose corresponding gene *CDH-1*is up-regulated by EGC, has been largely demonstrated to be involved in the establishment of a differentiated phenotype for IEC. Notably, E-Cadherin has been described to be less expressed at the bottom of the crypts where IEC are undifferentiated \[[@B16],[@B31],[@B32]\]. The down-regulation by EGC of *CDK5R1*expression, leading to enhanced levels of E-Cadherin (see previous paragraph), might also further enhance EGC-induced cell differentiation. EGC also increased *DCTN2*and *DYNLT3*expression, two genes encoding a subunit of dynactin (p50 or dynamitin) and dynein light chain rp3, respectively. Both are involved in post-Golgi movement of vesicles towards apical surface of differentiated enterocytes \[[@B33]-[@B35]\], and could therefore reflect increased differentiation of IEC induced by EGC. Intriguingly, although differentiation of the Caco-2 cell line has been shown to be correlated with a down-regulation in fibronectin expression \[[@B36]\], EGC induced an up-regulation in *FN1*expression in IEC in our study.

EGC decreased the expression of genes that encode proteins implicated in anti-differentiative pathways such as *E2F1, BAG1*and *CDK5R1*(discussed above). *E2F1*is a gene encoding a protein member of the E2F family of transcription factors and has been shown to be down-regulated in confluent human IEC and differentiated enterocytes \[[@B37]\]. *BAG1*, encoding a Bcl-2 non-homologous associated molecule, has also been shown to present a decreasing gradient of expression from the base of the crypts to the apex of the villi, suggesting that the down-regulation of *BAG1*might reflect a differentiation state of IEC \[[@B38]\].

In conclusion, based on our analysis, EGC-mediated regulation of IEC transcriptome appears to strongly favor IEC differentiation.

### Cell motility

EGC regulated in IEC the expression of genes encoding proteins that are known to play a role in IEC motility (Table [8](#T8){ref-type="table"}). In particular, EGC induced an increase in *FN1*expression in IEC. *FN1*has been demonstrated as a major factor in promoting cell migration of IEC and subepithelial fibroblasts, thus favoring epithelial wound healing \[[@B39],[@B40]\]. Interestingly, EGC induced a down-regulation in *LSP1*expression in IEC. *LSP1*gene encodes for LSP1, a cytoplasmic actin-binding protein, whose overexpression in melanoma cells has been described to inhibit cell motility \[[@B41]\]. EGC-induced up-regulation of *PTK2*expression also supports a role of EGC in promoting IEC motility. Indeed, increased FAK protein level promoted epithelial restitution *via*an increased IEC migration \[[@B42],[@B43]\]. Similarly, the increased PPARγ expression could enhance cell motility as inhibitors of PPARγ inhibit epithelial cell migration \[[@B44]-[@B46]\].

###### 

Genes controlling intestinal epithelial cells motility and modulated by enteric glial cells.

  Pro-motility      Anti-motility                                                
  ----------------- ------------------------------------------ ----------------- ------------------------------------------
  **Gene Symbol**   **Regulation of gene expression by EGC**   **Gene Symbol**   **Regulation of gene expression by EGC**
  PPARG             up-regulated                               LSP1              down-regulated
  FN1               up-regulated                                                 
  PTK2              up-regulated                                                 

### Cell proliferation

Expression of genes involved in cell proliferation was differentially regulated in IEC cultured in presence of EGC as compared to control (Table [9](#T9){ref-type="table"}). In fact, EGC appeared to modulate the expression of anti-proliferative and pro-proliferative genes toward a dominant anti-proliferative effect (Table [9](#T9){ref-type="table"}).

###### 

Genes controlling intestinal epithelial cells proliferation and modulated by enteric glial cells.

  Pro-proliferative   Anti-proliferative                                           
  ------------------- ------------------------------------------ ----------------- ------------------------------------------
  **Gene Symbol**     **Regulation of gene expression by EGC**   **Gene Symbol**   **Regulation of gene expression by EGC**
  E2F1                down-regulated                             TXNIP             up-regulated
  FGFR2               down-regulated                             BTG1              up-regulated
  PPIL1               down-regulated                             TP53RK            down-regulated
  MKI67               up-regulated                               SFRP4             down-regulated

The expression of major anti-proliferative and pro-proliferative genes was found to be up-regulated and down-regulated, respectively, by EGC. In particular, *PPARG*, *TXNIP*and *BTG1*expressions in IEC were up-regulated by EGC. PPARγ activation has been described both *in vivo*and *in vitro*to inhibit intestinal epithelial cell proliferation \[[@B47],[@B48]\] and to induce a G1 phase cell cycle arrest \[[@B27]\]. Furthermore, *TXNIP*encodes the thioredoxin-interacting protein, a negative regulator of thioredoxin. Thioredoxin is an important growth-promoting factor of IEC \[[@B49]\]. Moreover, *TXNIP*has also recently been suggested to be a tumor suppressor gene in hepatocellular carcinoma \[[@B50]\] and interestingly, *TXNIP*expression is decreased in colorectal cancer and ulcerative colitis \[[@B51]\]. Similarly, *BTG1*has been shown to negatively regulate cell proliferation and to present a maximal expression during G0/G1 phases of the cell cycle in fibroblasts \[[@B52]\]. Further reinforcing the anti-proliferative effects of EGC on IEC is the EGC-induced down-regulation of the expression of pro-proliferative genes such as *E2F1*, *FGFR2*and *PPIL1. E2F1*is a gene encoding a protein member of the E2F family of transcription factors that regulate cell cycle progression by modulating expression of proteins required for the G1/S transition. It has been well described that growth stimulatory signals lead to active E2F1 accumulation and S-phase entry \[[@B53],[@B54]\]. *FGFR2*encodes a member of the FGF (Fibroblast Growth Factor) receptor family with high affinity for KGF (Keratinocyte Growth Factor) which is a major actor in the mesenchymal stimulation of epithelial cell proliferation \[[@B55],[@B56]\]. Finally, *PPIL1*, which encodes a cyclophilin-related protein, PPIL1 (peptidyl prolyl isomerase-like protein), implicated in spliceosome activation, has recently been described to be overexpressed in colon tumors and *PPIL1*silencing led to an inhibition of colon cancer cell growth \[[@B57],[@B58]\].

These global anti-proliferative effects of EGC upon IEC have to be associated with the EGC-induced modulation of genes that would tend to be pro-proliferative, although these are clearly in reduced numbers. For instance, EGC increase *MKI67*expression, which encodes the proliferation marker Ki-67. Indeed, Ki-67 is increasingly expressed during the cell cycle phases \[[@B59]\], excepted in G0 or in cells just escaping from G0 \[[@B60]\]. Its function is still unclear but knock-down for Ki-67 in cancerous cells leads to an inhibition of proliferation mainly *via*an induction of apoptosis \[[@B61],[@B62]\]. Interestingly, EGC reduced the expression of *TP53RK*and *SFRP4*in IEC that encode proteins involved in anti-proliferative pathways. *TP53RK*encodes PRPK which is a short kinase that phosphorylates p53, enhancing its transcriptional activity \[[@B63]\] and suppressing cell cycle transition G1/S \[[@B64]\]. *SFRP4*encodes the protein sFRP4 (secreted frizzled-related protein), which is an inhibitor of the Wnt-signaling cascade through binding and sequestering Wnt ligand and, thus, has been shown to decrease cell proliferation in many cell lines \[[@B65]-[@B67]\].

Taken together, these data suggest that EGC tend to shift IEC transcriptome toward an anti-proliferative phenotype. These results could lead to the identification of specific targets responsible for the anti proliferative effects of EGC previously reported \[[@B12]\]. In addition, this global effect is supported further by the observation that EGC inhibit cell proliferation in part by inducing a cell cycle arrest in G0/G1 phase \[[@B11]\].

### Cell survival

EGC differentially regulated in IEC the expression of genes involved in cell death. EGC appeared to modulate the expression of anti-apoptotic and pro-apoptotic genes toward a dominant pro-apoptotic effect (Table [10](#T10){ref-type="table"}).

###### 

Genes controlling intestinal epithelial cells survival and modulated by enteric glial cells.

  Pro-apoptotic     Anti-apoptotic                                               
  ----------------- ------------------------------------------ ----------------- ------------------------------------------
  **Gene Symbol**   **Regulation of gene expression by EGC**   **Gene Symbol**   **Regulation of gene expression by EGC**
  BNIP3             up-regulated                               BAG1              down-regulated
  CASP4             up-regulated                               ASAH1             down-regulated
  CARD12            down-regulated                             GPX2              down-regulated
                                                               TUBB3             up-regulated

Indeed, expressions of pro-apoptotic and anti-apoptotic genes were found to be up-regulated and down-regulated, respectively, by EGC. In particular, *BNIP3*and *CASP4*expression in IEC were up-regulated by EGC. *CASP4*, coding for the caspase-4 pro-apoptotic protein has been shown to induce cell death \[[@B68],[@B69]\], like *BNIP3*which encodes a pro-apoptotic protein member of Bcl-2 family \[[@B70],[@B71]\]. Conversely, *ASAH-1, GPX2*and *BAG-1*were down-regulated by EGC. *BAG-1*encodes a known anti-apoptotic protein implicated in Bcl-2 signalling pathway \[[@B72],[@B73]\]. *ASAH-1*encodes acid ceramidase, an enzyme that catabolizes ceramide into sphingosine by deacylation. Overexpression of acid ceramidase in cells confers on them an increased resistance to cell death induced by various factors such as TNF (tumor necrosis factor) or anti-cancerous drugs \[[@B74],[@B75]\]. Finally, *GPX2*encodes a member of the glutathione peroxidase (GPX) family and is a selenoprotein and a glutathione peroxidase. GPX2 is expressed in IEC \[[@B76]\] and inhibits oxidative stress-induced apoptosis in the human breast adenocarcinoma cell line MCF-7 \[[@B77]\].

These global pro-apoptotic effects of EGC upon IEC have to be considered also in view of the EGC-mediated regulation of genes which would tend to be anti-apoptotic, although these are in reduced number. In particular, EGC up-regulated the expression of *TUBB3*, a gene encoding the class III isotype of β-tubulin. Silencing of class III β-tubulin by siRNA reverted anti-cancer agent-resistant cells to a sensitive phenotype and promoted apoptosis \[[@B78],[@B79]\]. Conversely, EGC inhibited the expression of *CARD12*which encodes the CARD12 protein, a member of the CED4/Apaf-1 family and known to induce apoptosis when expressed in cells \[[@B80],[@B81]\].

EGC-induced regulation of genes involved in cell death has probably no clear consequences on IEC survival. This is consistent with a previous study showing that EGC did not modify IEC survival \[[@B12]\].

Conclusion
==========

The present study described the impact of EGC upon the transcriptome of proliferating Caco-2 cells in a validated non-contact co-culture model of EGC and IEC \[[@B12],[@B13]\]. The results obtained confirmed the known role of EGC in the control of some IEB functions and, more interestingly, extended their role in the control of novel major IEB and IEC functions. This study further reinforced the emerging concept that EGC are an important component of the IEB environment with major protective effects. Indeed, the major pathways regulated by EGC in IEC identified with microarrays lead to enhanced cell adhesion, differentiation, and motility, which could favor repair, and reduced cell proliferation.

An important result of this study is the putative identification of genes involved in the anti-proliferative effects of EGC. Indeed, EGC have been shown to have potent anti-proliferative effects upon IEC \[[@B11],[@B12]\]. Interestingly, these effects were associated with an induction of a cell cycle blockade in the G0/G1 phase \[[@B11]\] but were not associated with significant cell death \[[@B12]\]. These results are globally confirmed, as there was no clear trend in the EGC-induced modulation of genes controlling cell survival in IEC but a trend toward an up-regulation of the expression of genes involved in anti-proliferative pathways.

A major finding of our study is that EGC regulated the expression of genes involved in cell adhesion and differentiation toward a global increase of IEC adhesive properties. These results can be analyzed in view of the known effects of EGC upon IEB. Indeed, *in vitro*studies have shown that EGC increase IEB resistance and decrease IEB paracellular permeability \[[@B13]\]. In the present study, we also demonstrated that EGC could increase global IEB adhesion, in part by increasing cell-to-matrix adhesion. These results are in agreement with *in vivo*data showing that selective lesions of EGC lead to increased paracellular permeability and major IEB breakdown associated with the development of intestinal inflammation. However, the role of the molecular actors involved in these processes such as fibronectin, laminin or cytokeratin remains to be investigated. EGC might also favor barrier integrity by increasing its resistance to inflammatory stress either by its ability to down-regulate inflammatory genes such as *CARD12*or by increasing IEC production of anti-inflammatory mediators such as VIP \[[@B82],[@B83]\].

Another important finding of this study is the observation that EGC might regulate IEC metabolism. In particular, EGC up-regulated genes involved in lipid metabolism such as *AADAC*, *MGLL*or *APOH*, encoding respectively the arylacetamide deacetylase, monoglyceride lipase (MGL) and Apolipoprotein H \[[@B84]-[@B86]\]. Interestingly, inhibitors of MGL which is a serine hydrolase that converts 2-arachidonoylglycerol, a ligand of canabinoid receptors, to fatty acids and glycerol, increased gut transit time \[[@B87]\] but its impact on IEB functions remain unknown. EGC also modulated the expression of genes involved in protein metabolism such as *CTSH*that encodes cathepsin H, a lysosomal cysteine proteinase \[[@B88]\]. In addition, EGC increased the expression of genes involved in arginine metabolic pathway that are *SLC7A7*and *ASS*, which encode respectively for the cationic amino acid transporter y(+)LAT1 and the argininosuccinate synthetase, enzyme catalyzing the penultimate step of the arginine biosynthetic pathways. The functional impact of EGC upon IEC metabolism needs to be investigated in future studies.

Regulation of IEB functions by EGC occurs mainly *via*paracrine pathways. The majority of EGC effects upon IEB functions are reproduced by glial-derived conditioned medium. In addition, various mediators have been identified as being involved in the control of cell proliferation or paracellular permeability. Our study supports the role of mediators such as TGF-β1 as a regulator of gene pathways modulated by EGC in IEC. In fact, TGF-β1 has been shown to increase the expression of FAK \[[@B43]\], TGFBI \[[@B89]\] or VIP \[[@B90]\]. EGC have also been shown to produce IL-6 \[[@B91]\]. IL-6 has recently been identified as a key molecule involved in IEB barrier protection *via*increasing both cytokeratin 8 and cytokeratin 18 proteins expression \[[@B92]\], whose mRNA expression were induced by EGC in IEC in our study. In this context, knowledge of genes modulated by EGC could direct future efforts aimed at identifying novel glial mediators involved in EGC control of IEB functions. Our data also further suggest that EGC differentially regulate some IEB functions as compared to fibroblasts, although comparison has only been performed on a limited set of genes and one cannot fully rule out that species differences could also be involved (fibroblasts of human origin *vs.*enteric glia of rat origin). However, these differences are consistent with the observation that while EGC have anti-proliferative effects on both human and rat IEC \[[@B12]\], fibroblasts increase IEC proliferation \[[@B93]\].

Collectively, our data support the concept that EGC play a key protective role upon IEB homeostasis by reinforcing global barrier functions. Additionally, our study reinforces data suggesting that enteric glia lesions and/or functional defects could be involved in the development of pathologies with altered barrier (such as inflammatory bowel diseases or colorectal cancer) and also be associated with increased barrier susceptibility to pathogen aggression.

Methods
=======

Cell culture
------------

CRL2690 (ATCC), a transformed EGC line isolated from adult rat myenteric plexus, was cultured in DMEM (4.5 g/L glucose; Gibco) supplemented with 10% heat-inactivated FBS, 2 mM glutamine (Gibco), 50 IU/mL penicillin and 50 μg/mL streptomycin. EGC were seeded at a concentration of 30,000 cells/mL in 6- and 12-well plates (Corning, Avon, France). EGC were cultured for an additional 24 hours after having reached confluence prior co-culture with IEC. CCD-18Co, a human colonic fibroblast cell line, was cultured in MEM Alpha Medium (Gibco) supplemented with 10% heat-inactivated FBS, 2 mM glutamine (Gibco), 0.1 mM MEM NEAA (Gibco), 50 IU/mL penicillin and 50 μg/mL streptomycin. Fibroblasts were seeded at a concentration of 130,000 cells/mL in 12-well plates (Corning). Fibroblats were cultured in EGC medium, as described above, for an additional 24 hours after having reached confluence prior co-culture with IEC. Caco-2 cells (ATCC), isolated from a human colonic adenocarcinoma, were cultured in DMEM (4.5 g/L glucose; Gibco) supplemented with 10% heat-inactivated FBS, 2 mM glutamine (Gibco), 50 IU/mL penicillin and 50 μg/mL streptomycin and were seeded at a concentration of 140,000 cells/mL onto porous Transwell filters (6-well and 12-well Transwell clear, 0.40 μm porosity, Corning). Caco-2 cells were processed for experiment 1 day after their seeding. To characterize EGC impact onto IEC transcriptome and functions, IEC seeded onto filters were cultured in presence of EGC seeded at the bottom of the 6-well or 12-well plates.

Microarray experiments
----------------------

Transcriptomic analysis was performed with a microarray of 6,864 genes called \"Cancerochip\" and available from the West Genopole transcriptome core facility of Nantes. These Cancerochips contained 6,864 probes (50-mers oligonucleotides), each specific of a single gene. These genes were selected to be preferentially and/or differentially expressed in Caco-2 cells and in various tumours. Three replicates of each probe were spotted onto Cancerochips. This allowed the measurement of the probes reproducibility within the array.

Total RNA was extracted from Caco-2 cells cultured on 6-well filters alone or in presence of EGC at t = 0, 8 and 24 hours. Each condition was performed in 4 replicates allowing the measurement of the reproducibility of the cell culture experiments. RNA extraction was performed with RNeasy mini kit (Qiagen) according to the manufacturer\'s recommendations.

The protocols used for subsequent amplification and labelling were described in the DNA chips platform protocols. Each individual sample was compared to a reference pool consisting of Caco-2 cells transcripts of the four replicates extracted at t = 0 hour. Total RNA (0.5 μg) was amplified and labelled using the Amino Allyl MessageAmp II aRNA Amplification kit (Ambion) and CyDye Post Labelling Reactive Dyes (Amersham). After reverse transcription to synthesize first strand cDNA, second strand cDNA was subsequently synthesized following the manufacturer\'s protocol. *In vitro*transcription was then achieved in order to amplify the initial transcripts quantity, concomitantly with aminoallyl-dUTP incorporation to perform labelling with cyanins (Cy5 for the reference and Cy3 for samples). The hybridization of the chips was performed following the protocol of the West Genopole transcriptome core facility of Nantes. After washing, the chips were scanned (Scanexpress- Perkin Elmer).

Data analysis
-------------

After acquisition, the scanned images were analyzed using GenePix Pro v5.1 software (Axon). Raw signals were processed using the MADSCAN package <http://cardioserve.nantes.inserm.fr/mad/madscan/>. Spots with weak, saturated signal or badly shaped were considered as missing values. Print-tip lowess was applied to raw signals to normalize both channels (Cy3 and Cy5) of a same array. Fitting coefficients were calculated on rank invariant spots, assuming that they correspond to ubiquitous genes (genes that did not vary between samples). Sample to reference ratios (Cy3/Cy5) were further calculated, and Log transformed (Expression Logratios). Probes with more than 25% of missing values were rejected.

In order to identify differentially expressed genes, Expression Logratios were analyzed using Genespring v7.0 software (Agilent Technologies). Genes differentially expressed between Caco-2 cells cultured alone or in presence of EGC were searched with Benjamini and Hochberg False Discovery Rate method with a significance threshold of 0.05. This method includes a correction for multi-testing and has been widely used for microarray data \[[@B94]\]. This analysis led to the identification of 98 genes differentially expressed in IEC cultured in presence of EGC as compared to control, i.e. IEC cultured alone at t = 24 hours and none at t = 8 hours. Analysis of variance (ANOVA) using time of culture and presence/absence of ECG as parameters gave very similar results. Data visualization using hierarchical clustering and Volcano-Plot suggested that this strategy might have missed some differentially expressed genes at t = 24 hours; we thus selected an additional set of genes based on expression fold-changes. Twenty seven genes with a fold-change threshold of 2 and a t-test p-value \< 0.05 without multi-testing correction were found. Altogether 116 unique genes were found differentially expressed in IEC at t = 24 hours of culture in presence of EGC as compared to control.

Hierarchical clustering was performed after normalization on medians of the ratio values of the t = 0 hour-condition samples. Hierarchical clustering was performed using the Cluster software. It was applied to order either genes and samples or genes only. It creates a visualization of the grouping of genes and samples based on profile similarity, even if it does not provide robustness assessment of the classification.

Among the 116 genes identified with Genespring analysis, 17 of them did not present reliable values at t = 0 hour. Thus, these 17 genes were excluded from hierarchical clustering analyses. As a consequence, clustering analyses only involved 99 genes.

Microarray data were uploaded to GEO database <http://www.ncbi.nlm.nih.gov/geo/> and are available under the access number GSE17027.

RT-quantitative PCR
-------------------

Extraction of total RNA from Caco-2 cells cultured alone, in presence of EGC or fibroblasts for 24 hours was performed with RNeasy Mini kit (Qiagen) according to the manufacturer\'s protocol. For reverse transcription, 1 μg of purified total RNA was denatured and subsequently processed for reverse transcription using SuperScript II Reverse Transcriptase (Invitrogen) according to the manufacturer\'s recommendations. PCR amplifications were performed using the Absolute Blue SYBR green fluorescein kit (ABgene) according to the manufacturer\'s protocol and run on MyiQ thermocycler (Biorad). The expression of the gene *S6*was analyzed in parallel as an internal control.

***CDH1***\[GenBank: [NM_004360](NM_004360)\]

Forward primer:

5\'-GACCAGGACTATGACTACTTGAACG-3\'

Reverse primer:

5\'-ATCTGCAAGGTGCTGGGTGAACCTT-3\'

***E2F1***\[GenBank: [NM 005225](NM 005225)\]

Forward primer:

5\'-CCGCTCGAGGAGAAGTCACGCTATGA-3\'

Reverse primer:

5\'-CCCAAGCTTTTGGTGATGTCATAGATGC-3\'

***FN1***\[GenBank: [NM_054034](NM_054034)\]

Forward primer:

5\'-GCAGGCTCAGCAAATGGTTCAG-3\'

Reverse primer:

5\'-AGGTAGGTCCGCTCCCACTG-3\'

***FGFR2***\[GenBank: [NM_022970](NM_022970)\]

Forward primer:

5\'-GTCCTGCCAAAACAGCAAG-3\'

Reverse primer:

5\'-CCCCTATGCAGTAAATGGCTA-3\'

***GPX2***\[GenBank: [NM_002083](NM_002083)\]

Forward primer:

5\'-gtccttggcttcccttgc-3\'

Reverse primer:

5\'-tgttcaggatctcctcattctg-3\'

***LAMA5***\[GenBank: [NM_005560](NM_005560)\]

Forward primer:

5\'-CCCACCGAGGACCTTTACTGC-3\'

Reverse primer:

5\'-GGTGTGCCTTGTTGCTGTTGG-3\'

***PPARG***\[GenBank: [NM_138712](NM_138712)/[NM_005037](NM_005037)/[NM_138711](NM_138711)/[NM_015869](NM_015869)\]

Forward primer:

5\'-ttgctgtcattattctcagtgga-3\'

Reverse primer:

5\'-gaggactcagggtggttcag-3\'

***PTK2***\[GenBank: [NM_153831](NM_153831)/[NM_005607](NM_005607)\]

Forward primer:

5\'- GAGATCCTGTCTCCAGTCTAC-3\'

Reverse primer:

5\'- TGCACCTGCTATTTTTAGTTG-3\'

***SMAD3***\[GenBank: NM 005902\]

Forward primer:

5\'-CCAAGCTTAGAACGGGCAGGAGGAG-3\'

Reverse primer:

5\'-CACTCGAGTGGTGGCTGTGCAGGTC-3\'

***S6***\[GenBank: [NM_001010](NM_001010)\]

Forward primer:

5\'-TGGCAAGATGATCCCAATGA-3\'

Reverse primer:

5\'-AGCTTCTTTGGGACACCTGCT-3\'

Adhesion experiments
--------------------

### Global adhesion assay

IEC adhesion was estimated by performing a \"global adhesion assay\" that evaluated total IEC adhesion to their environment, i.e. adhesion to neighboring IEC and adhesion to matrix. IEC were cultivated on filters (12-well Transwell clear, 0.40 μm porosity, Corning) alone or in the presence of EGC for 24 hours. IEC were then trypsinized with 0.01% trypsin-EDTA free (Sigma) allowing gentle trypsinization for 30 minutes at 37°C. Non-adherent IEC were harvested and counted in a blind fashion using Malassez slides (VWR international). IEC remaining adhered on filters were trypsinized with 2.5% trypsin with EDTA (Gibco), harvested and counted. Results are expressed in percentage of remaining adherent IEC normalized to the total number of counted IEC (i.e., adherent IEC and non-adherent IEC). Only those series in which the percentage of IEC total adhesion in control condition was comprised between 20 and 70% were analyzed.

### Cell-to-matrix adhesion assay

IEC were cultivated on filters (12-well Transwell clear, 0.40 μm porosity, Corning) alone or in presence of EGC for 24 hours. IEC were then trypsinized for 10 minutes with a 2.5% trypsin-EDTA (Gibco). Trypsin was neutralized with IEC culture medium (see above). IEC were subsequently reseeded on filters and incubated for 3 hours at 37°C. Time of incubation has been defined to allow 50% of seeded IEC to adhere to filters in control condition. Following incubation, unseeded cells were harvested and counted in a blind fashion using Malassez slides (VWR international). IEC that had adhered on filters were trypsinized and counted. Results are expressed in percentage of adherent IEC normalized to the total number of counted IEC (i.e., adherent IEC and non-adherent IEC). Only those series in which the percentage of IEC total adhesion in control condition was comprised between 20 and 70% were analyzed.
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